We conclude that a duodenal dual-wavelength light-emitting diode photobiomodulation improves hyperglycemia and hepatic parameters through photobiomodulation-mediated change of serum insulin, insulin resistance, insulin expression in the pancreatic β-cells, and the gut microbiome. The gene discussed is INS; the disease is Hyperglycemia.